Skip to main content
NCBI home page
Infection and Immunity logoLink to Infection and Immunity
. 1983 Feb;39(2):709–714. doi: 10.1128/iai.39.2.709-714.1983

Efficacy of Human Hyperimmune Globulin in Prevention of Haemophilus influenzae Type b Disease in Infant Rats

Donna Ambrosino 1, John R Schreiber 2, Robert S Daum 3, George R Siber 1,4,*
PMCID: PMC348007  PMID: 6601060

Abstract

To determine the protective efficacy of human hyperimmune globulin to Haemophilus influenzae type b disease in an infant rat model, we compared hyperimmune globulin containing 600 μg of anti-polyribophosphate (PRP) antibody per ml to conventional immune globulin containing 66 μg of anti-PRP antibody per ml. The hyperimmune globulin was fractionated from the pooled plasma of 55 adult donors immunized with PRP, the capsular polysaccharide of H. influenzae type b. The disappearance of passively administered antibody was biphasic, with a linear first-order disappearance curve during the first 7 days. The initial half-life for anti-PRP antibody was 2.38 days in rats nasally colonized but not detectably bacteremic with H. influenzae type b and significantly longer (half-life, 10.3 days; P < 0.01) in noncolonized animals. Hyperimmune globulin afforded 10 times the protection of conventional globulin against bacteremia and meningitis. Globulin depleted of anti-PRP antibody offered no protection. The initial serum antibody levels and the levels during the 8-day observation period predicted protection. Rats maintaining serum antibody levels greater or equal to 50 ng/ml to day 8 had a 10% bacteremia and 5% meningitis incidence in contrast with 95% bacteremia (P < 0.001) and 55% meningitis (P < 0.001) in rats with less than 50 ng of anti-PRP antibody per ml. We conclude that studies of the pharmacology and efficacy of hyperimmune globulin are warranted in high-risk children unable to respond to active immunization.

Full text

PDF
709

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Anderson P. Intrinsic tritium labeling of the capsular polysaccharide antigen of Haemophilus influenzae type B. J Immunol. 1978 Mar;120(3):866–870. [PubMed] [Google Scholar]
  2. Anderson P., Smith D. H. Isolation of the capsular polysaccharide from culture supernatant of Haemophilus influenzae type b. Infect Immun. 1977 Feb;15(2):472–477. doi: 10.1128/iai.15.2.472-477.1977. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. COHEN S., HANSEN J. D. Metabolism of albumin and gamma-globulin in kwashiorkor. Clin Sci. 1962 Oct;23:351–359. [PubMed] [Google Scholar]
  4. Clarke R. M., Hardy R. N. The use of [125-I] polyvinyl pyrrolidone K. 60 in the quantitative assessment of the uptake of macromolecular substances by the intestine of the young rat. J Physiol. 1969 Sep;204(1):113–125. doi: 10.1113/jphysiol.1969.sp008902. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Coulehan J. L., Michaels R. H., Williams K. E., Lemley D. K., North C. Q., Jr, Welty T. K., Rogers K. D. Bacterial meningitis in Navojo Indians. Public Health Rep. 1976 Sep-Oct;91(5):464–468. [PMC free article] [PubMed] [Google Scholar]
  6. Haemophilus influenzae type b: disease and immunity in humans. Ann Intern Med. 1973 Feb;78(2):259–269. doi: 10.7326/0003-4819-78-2-259. [DOI] [PubMed] [Google Scholar]
  7. Halsey N. A., Korock C., Johansen T. L., Glode M. P. Intralitter transmission of haemophilus influenzae type b in infant rats and rifampin eradication of nasopharyngeal colonization. J Infect Dis. 1980 Nov;142(5):739–743. doi: 10.1093/infdis/142.5.739. [DOI] [PubMed] [Google Scholar]
  8. Moxon E. R., Smith A. L., Averill D. R., Smith D. H. Haemophilus influenzae meningitis in infant rats after intranasal inoculation. J Infect Dis. 1974 Feb;129(2):154–162. doi: 10.1093/infdis/129.2.154. [DOI] [PubMed] [Google Scholar]
  9. Peppard J. V., Orlans E. The biological half-lives of four rat immunoglobulin isotypes. Immunology. 1980 Aug;40(4):683–686. [PMC free article] [PubMed] [Google Scholar]
  10. Smith D. H., Peter G., Ingram D. L., Harding A. L., Anderson P. Responses of children immunized with the capsular polysaccharide of Hemophilus influenzae, type b. Pediatrics. 1973 Nov;52(5):637–644. [PubMed] [Google Scholar]
  11. Stiehm E. R., Vaerman J. P., Fudenberg H. H. Plasma infusions in immunologic deficiency states: metabolic and therapeutic studies. Blood. 1966 Dec;28(6):918–937. [PubMed] [Google Scholar]
  12. Ward J. I., Margolis H. S., Lum M. K., Fraser D. W., Bender T. R., Anderson P. Haemophilus influenzae disease in Alaskan Eskimos: characteristics of a population with an unusual incidence of invasive disease. Lancet. 1981 Jun 13;1(8233):1281–1285. doi: 10.1016/s0140-6736(81)92458-2. [DOI] [PubMed] [Google Scholar]
  13. Weller P. F., Smith A. L., Smith D. H., Anderson P. Role of immunity in the clearance of bacteremia due to Haemophilus influenzae. J Infect Dis. 1978 Oct;138(4):427–436. doi: 10.1093/infdis/138.4.427. [DOI] [PubMed] [Google Scholar]

Articles from Infection and Immunity are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES